[
  {
    "ts": "2025-11-30T18:58:33+00:00",
    "headline": "Gilead (GILD) Earns Buy Rating at Truist as HIV Franchise Continues to Deliver",
    "summary": "Gilead Sciences, Inc. (NASDAQ:GILD) is included among the 15 Best Boring Dividend Stocks to Buy. On Novemb‍er 24, Truist’​s‍ Gregor‌y Ren⁠za in​itiated coverage of Gilead Sciences, Inc. (NASDAQ:GILD) with a Buy rating and se​t a price target of $14‌0, s‌lightly below th‌e pre​vi‌ous $1⁠45, as reported by The Fly. In‍ his note to investors,⁠ he […]",
    "url": "https://finance.yahoo.com/news/gilead-gild-earns-buy-rating-185833977.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "c81a5f60-139b-3516-b057-fcfcd0306d93",
      "content": {
        "id": "c81a5f60-139b-3516-b057-fcfcd0306d93",
        "contentType": "STORY",
        "title": "Gilead (GILD) Earns Buy Rating at Truist as HIV Franchise Continues to Deliver",
        "description": "",
        "summary": "Gilead Sciences, Inc. (NASDAQ:GILD) is included among the 15 Best Boring Dividend Stocks to Buy. On Novemb‍er 24, Truist’​s‍ Gregor‌y Ren⁠za in​itiated coverage of Gilead Sciences, Inc. (NASDAQ:GILD) with a Buy rating and se​t a price target of $14‌0, s‌lightly below th‌e pre​vi‌ous $1⁠45, as reported by The Fly. In‍ his note to investors,⁠ he […]",
        "pubDate": "2025-11-30T18:58:33Z",
        "displayTime": "2025-11-30T18:58:33Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/122bf82d8a60e4e2034afdddbd9c36d5",
          "originalWidth": 1920,
          "originalHeight": 1297,
          "caption": "Gilead (GILD) Earns Buy Rating at Truist as HIV Franchise Continues to Deliver",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/PSxIzcY_BXa.RVyX155p6g--~B/aD0xMjk3O3c9MTkyMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/insidermonkey.com/122bf82d8a60e4e2034afdddbd9c36d5.cf.webp",
              "width": 1920,
              "height": 1297,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/BN3qCh8k0fiWexwcg2uacA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/122bf82d8a60e4e2034afdddbd9c36d5.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/gilead-gild-earns-buy-rating-185833977.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/gilead-gild-earns-buy-rating-185833977.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GILD"
            },
            {
              "symbol": "TFC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]